Contraceptive prevalence, any modern method in Sierra Leone
Sierra Leone: Contraceptive prevalence, any modern method was 20.9% in 2019. ◆ Volatile
Contraceptive prevalence, any modern method in Sierra Leone, 2000–2019
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Sierra Leone is 20.9%, measured in 2019.
That represents a change of down 4.3% on the previous year and up 211.9% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Sierra Leone peaked at 21.9% in 2017 and was at its lowest, 3.9%, in 2000.
Sierra Leone ranks 96th of 113 countries on this measure, in the bottom quarter.
Contraceptive prevalence, any modern method in Sierra Leone, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 2000 | 3.9% | — |
| 2006 | 4.9% | +24.1% |
| 2008 | 6.7% | +37.3% |
| 2010 | 10.2% | +52.2% |
| 2013 | 15.6% | +53.0% |
| 2017 | 21.9% | +40.1% |
| 2019 | 20.9% | -4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.2% | 3.9% | 6.7% | 3 |
| 2010s | 17.1% | 10.2% | 21.9% | 4 |
Countries ranked near Sierra Leone
More health data for Sierra Leone
- Un projection of annual infant deaths, annual growth rate -2.34 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,199 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,209 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 38 (2025)
- Population ages 00-04, female, annual growth rate 0.6447 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.6611 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Sierra Leone?
- Contraceptive prevalence, any modern method in Sierra Leone was 20.9% in 2019, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Sierra Leone?
- The highest recorded value was 21.9% in 2017.
- What is the lowest contraceptive prevalence, any modern method recorded in Sierra Leone?
- The lowest recorded value was 3.9% in 2000.
- How does Sierra Leone rank for contraceptive prevalence, any modern method?
- Sierra Leone ranks 96th out of 113 countries with data for 2019.
- Is contraceptive prevalence, any modern method rising or falling in Sierra Leone?
- Over the last ten years it is up 211.9%. The long-run trend across the full record is volatile.
- Where does this Sierra Leone data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.